Sunday, December 8, 2019
Latest:
  • Up-to-date Trial for PSMA-Targeted Treatments in Metastatic Prostate Cancer Excites
  • ASCO GU 2019: period II demo concerts novel, radiolabelled treatment that is PSMA-targeted higher reaction costs in boys with metastatic prostate disease
  • Lutetium-177-PSMA-617 in Low Amount Metastatic Prostate Cancer Tumors
  • Radioligand Treatments Attains Feedback in Metastatic Prostate Cancer Tumors
  • Lutetium PSMA Therapy

wwwcancer.co.uk

  • Cancer Lutetium
  • PSMA Therapy in Metastatic prostate
  • Prostate Cancer
  • Lung cancer
  • Stomach cancer

Month: May 2019

PSMA Therapy in Metastatic prostate 

Up-to-date Trial for PSMA-Targeted Treatments in Metastatic Prostate Cancer Excites

07.05.201907.05.2019 0 Comments

The investigational radiolabeled lightweight molecule that targets prostate-specific membrane layer antigen (PSMA), lutetium-177 PSMA-617 (LuPSMA), conferred a high responses speed

Read more
PSMA Therapy in Metastatic prostate 

ASCO GU 2019: period II demo concerts novel, radiolabelled treatment that is PSMA-targeted higher reaction costs in boys with metastatic prostate disease

07.05.201907.05.2019 0 Comments

A single-arm, phase II trial in men with PSMA-positive metastatic, castration-resistant prostate disease (mCRPC) that evolved despite regular therapies, discovered

Read more
PSMA Therapy in Metastatic prostate 

Lutetium-177-PSMA-617 in Low Amount Metastatic Prostate Cancer Tumors

07.05.201907.05.2019 0 Comments

Radioligand treatments (RLT) using Lu-177 branded PSMA are a promising newer therapeutic method to manage prostate cancer that is metastatic.

Read more
Cancer Lutetium 

Radioligand Treatments Attains Feedback in Metastatic Prostate Cancer Tumors

07.05.201907.05.2019 0 Comments

A unique approach getting a tumor-specific radioligand therapy that binds to prostate-specific membrane layer antigen (PSMA) (lutetium-177 PSMA-617 -[LuPSMA]) gained

Read more
Cancer Lutetium 

Lutetium PSMA Therapy

07.05.201907.05.2019 0 Comments

What is Lutetium PSMA Therapies? Lutetium-177 PSMA therapies, or Prostate-Specific Membrane Antigen treatment, was treatment this is certainly progressively used

Read more
Cancer Lutetium 

ASCO 2018: Lutetium-177 PSMA617 Theranostics In Metastatic Castrate-Resistant Prostate cancers: meantime Results of a state II test

07.05.201907.05.2019 0 Comments

Chicago, IL (UroToday.com) Lutetium-177 (177Lu)-PSMA617 (LuPSMA) is a smaller radiolabeled anti-prostate-specific membrane layer antigen (PSMA) monoclonal antibody which combines the

Read more
Prostate Cancer 

Treating prostate disease

07.05.201907.05.2019 0 Comments

Your treatment for prostate malignant tumors will depend on the individual conditions. No treatment will be necessary for many men

Read more
Prostate Cancer 

How Curable is actually Prostate Malignant Tumors

07.05.201907.05.2019 0 Comments

Are Prostate Cancer Tumors Curable? Prostate malignant tumors is considered the most usual style of cancer among boys, second simply

Read more
Prostate Cancer 

Radiation for Prostate Malignant Tumors

07.05.201907.05.2019 0 Comments

What’s Radiotherapy? Radiation is the strategic utilization of ionizing radiation or photons to kill cancer tissues. It functions by damaging

Read more
Lung cancer 

What Are the Therapy for Lung Cancer?

07.05.201907.05.2019 0 Comments

The recommended treatment for cancer of the lung will depend on which kind of cancer someone have plus the level

Read more
  • ← Previous
May 2019
M T W T F S S
     
 12345
6789101112
13141516171819
20212223242526
2728293031  

wwwcancer.co.uk – 2019